Journal Article

DKFZ-2026-01474

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Plasma PlGF as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS Trial

Hille, J. ; Lorenzen, S. ; Pauligk, C. ; Gensch, V.DKFZ* ; Thuss-Patience, P. ; Goekkurt, E. ; Ettrich, T. ; Lordick, F. ; Bokemeyer, C. ; Müller, C. ; Reichardt, P. ; Sökler, M. ; Pink, D. ; Probst, S. ; Goetze, T. O. ; Al-Batran, S. E. ; Loges, S.DKFZ* ; Janning, M. (Last author)DKFZ*

2026
Wiley-Liss Bognor Regis

Note: #LA:A420# SCOPUS/ epub

---

Contributing Institute(s):

1. Personalisierte Medizinische Onkologie (A420)

Research Program(s):

1. 311 - Zellbiologie und Tumorbiologie (POF4-311) (POF4-311)

Appears in the scientific report 2026

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---